Iskandar, B. J. & Finnell, R. H. Spina bifida. N. Engl. J. Med. 387, 444–450 (2022).
Lee, S. & Gleeson, J. G. Closing in on mechanisms of open neural tube defects. Trends Neurosci. 43, 519–532 (2020).
MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 338, 131–137 (1991).
Arnold, J. A. Myelocyste, transposition von gewebskeimen und sympodie. Beitr. Pathol. Anat. 16, 1–28 (1894).
Chiari, H. Uber veränderungen des kleinhirns infolge von hydrocephalie des grosshirns. Dtsch. Med. Wochenschr. 17, 1172–1175 (1891).
Wilde, J. J., Petersen, J. R. & Niswander, L. Genetic, epigenetic, and environmental contributions to neural tube closure. Annu. Rev. Genet. 48, 583–611 (2014).
Carter, C. O. & Evans, K. Spina bifida and anencephalus in greater London. J. Med. Genet. 10, 209–234 (1973).
Zhang, T. et al. Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature. PLoS ONE 8, e59570 (2013).
Lei, Y. et al. Identification of novel CELSR1 mutations in spina bifida. PLoS ONE 9, e92207 (2014).
Kibar, Z. et al. Mutations in VANGL1 associated with neural-tube defects. N. Engl. J. Med. 356, 1432–1437 (2007).
Morrison, K. et al. Genetic mapping of the human homologue (T) of mouse T (Brachyury) and a search for allele association between human T and spina bifida. Hum. Mol. Genet. 5, 669–674 (1996).
Jensen, L. E., Etheredge, A. J., Brown, K. S., Mitchell, L. E. & Whitehead, A. S. Maternal genotype for the monocyte chemoattractant protein 1 A(-2518)G promoter polymorphism is associated with the risk of spina bifida in offspring. Am. J. Med. Genet. A 140, 1114–1118 (2006).
Iossifov, I. et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515, 216–221 (2014).
Zaidi, S. et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 498, 220–223 (2013).
Lemay, P. et al. Loss-of-function de novo mutations play an important role in severe human neural tube defects. J. Med. Genet. 52, 493–497 (2015).
Fischbach, G. D. & Lord, C. The Simons Simplex Collection: a resource for identification of autism genetic risk factors. Neuron 68, 192–195 (2010).
Rahbari, R. et al. Timing, rates and spectra of human germline mutation. Nat. Genet. 48, 126–133 (2016).
Kessler, M. D. et al. De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population. Proc. Natl Acad. Sci. USA 117, 2560–2569 (2020).
Besenbacher, S. et al. Novel variation and de novo mutation rates in population-wide de novo assembled Danish trios. Nat. Commun. 6, 5969 (2015).
Frome, E. L. The analysis of rates using Poisson regression models. Biometrics 39, 665–674 (1983).
Willsey, A. J. et al. De novo coding variants are strongly associated with Tourette disorder. Neuron 94, 486–499 (2017).
Dong, C. et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum. Mol. Genet. 24, 2125–2137 (2015).
Kong, A. et al. Rate of de novo mutations and the importance of father’s age to disease risk. Nature 488, 471–475 (2012).
Goldmann, J. M., Veltman, J. A. & Gilissen, C. De novo mutations reflect development and aging of the human germline. Trends Genet. 35, 828–839 (2019).
Turner, T. N. et al. Genomic patterns of de novo mutation in simplex autism. Cell 171, 710–722 (2017).
Martin, J. et al. A brief report: de novo copy number variants in children with attention deficit hyperactivity disorder. Transl. Psychiatry 10, 135 (2020).
Sanders, S. J. et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70, 863–885 (2011).
Hol, F. A. et al. A frameshift mutation in the gene for PAX3 in a girl with spina bifida and mild signs of Waardenburg syndrome. J. Med. Genet. 32, 52–56 (1995).
Szklarczyk, D. et al. The STRING database in 2023: protein–protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638–D646 (2023).
Cowen, L., Ideker, T., Raphael, B. J. & Sharan, R. Network propagation: a universal amplifier of genetic associations. Nat. Rev. Genet. 18, 551–562 (2017).
Harris, M. J. & Juriloff, D. M. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res. A Clin. Mol. Teratol. 88, 653–669 (2010).
Traag, V. A., Waltman, L. & van Eck, N. J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 9, 5233 (2019).
Rolo, A., Escuin, S., Greene, N. D. E. & Copp, A. J. Rho GTPases in mammalian spinal neural tube closure. Small GTPases 9, 283–289 (2018).
Wallingford, J. B., Niswander, L. A., Shaw, G. M. & Finnell, R. H. The continuing challenge of understanding, preventing, and treating neural tube defects. Science 339, 1222002 (2013).
Niederkofler, V., Salie, R., Sigrist, M. & Arber, S. Repulsive guidance molecule (RGM) gene function is required for neural tube closure but not retinal topography in the mouse visual system. J. Neurosci. 24, 808–818 (2004).
Kee, N., Wilson, N., Key, B. & Cooper, H. M. Netrin-1 is required for efficient neural tube closure. Dev. Neurobiol. 73, 176–187 (2013).
Greene, N. D., Stanier, P. & Moore, G. E. The emerging role of epigenetic mechanisms in the etiology of neural tube defects. Epigenetics 6, 875–883 (2011).
Akimova, D. et al. Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects. Birth Defects Res. 109, 106–119 (2017).
Copp, A. J., Stanier, P. & Greene, N. D. Neural tube defects: recent advances, unsolved questions, and controversies. Lancet Neurol. 12, 799–810 (2013).
Schaar, B. T. & McConnell, S. K. Cytoskeletal coordination during neuronal migration. Proc. Natl Acad. Sci. USA 102, 13652–13657 (2005).
Dent, E. W., Gupton, S. L. & Gertler, F. B. The growth cone cytoskeleton in axon outgrowth and guidance. Cold Spring Harb. Perspect. Biol. 3, a001800 (2011).
Geelen, J. A. & Langman, J. Closure of the neural tube in the cephalic region of the mouse embryo. Anat. Rec. 189, 625–640 (1977).
Rolo, A. et al. Regulation of cell protrusions by small GTPases during fusion of the neural folds. eLife 5, e13273 (2016).
Hamosh, A., Scott, A. F., Amberger, J. S., Bocchini, C. A. & McKusick, V. A. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 33, D514–D517 (2005).
Jin, S. C. et al. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat. Genet. 49, 1593–1601 (2017).
Halvorsen, M. et al. De novo mutations in childhood cases of sudden unexplained death that disrupt intracellular Ca2+ regulation. Proc. Natl Acad. Sci. USA 118, e2115140118 (2021).
Li, W. et al. De novo mutations contributes approximately 7% of pathogenicity in inherited eye diseases. Invest. Ophthalmol. Vis. Sci. 64, 5 (2023).
Boyle, E. A., Li, Y. I. & Pritchard, J. K. An expanded view of complex traits: from polygenic to omnigenic. Cell 169, 1177–1186 (2017).
Lemos, M. C. et al. Genetic background influences embryonic lethality and the occurrence of neural tube defects in Men1 null mice: relevance to genetic modifiers. J. Endocrinol. 203, 133–142 (2009).
Momb, J. et al. Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice. Proc. Natl Acad. Sci. USA 110, 549–554 (2013).
Chen, Z. et al. Threshold for neural tube defect risk by accumulated singleton loss-of-function variants. Cell Res. 28, 1039–1041 (2018).
Bassuk, A. G. et al. Copy number variation analysis implicates the cell polarity gene glypican 5 as a human spina bifida candidate gene. Hum. Mol. Genet. 22, 1097–1111 (2013).
Rendeli, C. et al. Assessment of health status in children with spina bifida. Spinal Cord 43, 230–235 (2005).
Dimitromanolakis, A., Paterson, A. D. & Sun, L. Fast and accurate shared segment detection and relatedness estimation in un-phased genetic data via TRUFFLE. Am. J. Hum. Genet. 105, 78–88 (2019).
Lee, J. et al. Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures. Nucleic Acids Res. 46, W102–W108 (2018).
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
Ioannidis, N. M. et al. REVEL: An ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877–885 (2016).
Jaganathan, K. et al. Predicting splicing from primary sequence with deep learning. Cell 176, 535–548 (2019).
Giacopuzzi, E., Popitsch, N. & Taylor, J. C. GREEN-DB: a framework for the annotation and prioritization of non-coding regulatory variants from whole-genome sequencing data. Nucleic Acids Res. 50, 2522–2535 (2022).
Suvakov, M., Panda, A., Diesh, C., Holmes, I. & Abyzov, A. CNVpytor: a tool for copy number variation detection and analysis from read depth and allele imbalance in whole-genome sequencing. Gigascience 10, giab074 (2021).
Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 32, 1220–1222 (2016).
Rausch, T. et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics 28, i333–i339 (2012).
Chen, K. H., Boettiger, A. N., Moffitt, J. R., Wang, S. & Zhuang, X. RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells. Science 348, aaa6090 (2015).
Delile, J. et al. Single cell transcriptomics reveals spatial and temporal dynamics of gene expression in the developing mouse spinal cord. Development 146, dev173807 (2019).
Soldatov, R. et al. Spatiotemporal structure of cell fate decisions in murine neural crest. Science 364, eaas9536 (2019).
Simões-Costa, M. & Bronner, M. E. Establishing neural crest identity: a gene regulatory recipe. Development 142, 242–257 (2015).
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
Komatsu, N. et al. Development of an optimized backbone of FRET biosensors for kinases and GTPases. Mol. Biol. Cell 22, 4647–4656 (2011).
Rosenthal, S. B. et al. Mapping the common gene networks that underlie related diseases. Nat. Protoc. 18, 1745–1759 (2023).
Huang, J. K. et al. Systematic evaluation of molecular networks for discovery of disease genes. Cell Syst. 6, 484–495 (2018).
Duman, R. S., Sanacora, G. & Krystal, J. H. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 102, 75–90 (2019).
Tolias, K. F. et al. The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines. Neuron 45, 525–538 (2005).
Duman, J. G. et al. The adhesion-GPCR BAI1 shapes dendritic arbors via Bcr-mediated RhoA activation causing late growth arrest. eLife 8, e47566 (2019).
Henrie, H. et al. Stress-induced phosphorylation of CLIP-170 by JNK promotes microtubule rescue. J. Cell Biol. 219, e201909093 (2020).
Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024).
Adasme, M. F. et al. PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA. Nucleic Acids Res. 49, W530–W534 (2021).
Santos-Martins, D. et al. Accelerating AutoDock4 with GPUs and gradient-based local search. J. Chem. Theory Comput. 17, 1060–1073 (2021).
Sive, H., Grainger, R. M. & Harland, R. M. Early Development of Xenopus laevis: A Laboratory Manual (Cold Spring Harbor Laboratory Press, 2000).
